Topic
Bench to bedside
How a discovery becomes a tool a clinician will actually use.
This page collects every article by Dr. Damon Tojjar in this topic. For all topics see browse by topic, and for the source-anchored record see damontojjar.com/record.
Articles in this topic (10)
- From bench to clinic: building technology clinicians trust
My path moved deliberately from discovery to translation: diabetes genetics at Lund, systems medicine at Stanford, global clinical development at Novo Nordisk, and...
- From Bench to Bedside in Diabetes: Why So Few Discoveries Reach a Patient
Most diabetes discoveries never reach a patient. A gene that looks promising in a Petri dish, a receptor that behaves oddly in a mouse, a statistical signal in a...
- What Global Clinical Development Actually Involves
Global clinical development is the long, careful process of proving that a treatment works and is safe enough across many countries and many kinds of patients...
- How a Biotech Idea Moves From the Lab to the Clinic
A biotech idea becomes a tested product through a long chain of go or no-go decisions, and most ideas fail at one of them. The path runs from a biological...
- Umbrella, Basket, and Platform Trials: What the FDA's Master-Protocol Guidance Actually Changes
The FDA's revised draft guidance on master protocols, published in the Federal Register on June 24, 2026, does not invent umbrella, basket, and platform trials. It...
- How the RECOVERY Trial Found an Answer in 100 Days: Adaptive Platform Design Explained
An answer in about 100 daysThe RECOVERY trial went from a first protocol draft to a practice-changing answer in roughly 100 days because it used one master protocol...
- The Translation Gap: Why Good Research Rarely Becomes a Tool Clinicians Use
A promising research finding fails to become a tool clinicians use for four reasons, and only one of them is the science. The finding has to be validated outside...
- The Valley of Death in Translational Research: Why Good Science Stalls
The valley of death in translational research is the stretch between a published, reproducible finding and a product anyone can use, and most findings die there for...
- Why So Many Promising Discoveries Never Reach Patients
Most promising biomedical discoveries never reach a patient, and the reason is rarely that the science was wrong. A finding can be real, elegant, and reproducible...
- Why Health-Technology Pilots Succeed and Then Fail to Scale
A health-technology pilot succeeds and then fails to scale because it quietly supplied everything the product could not yet supply on its own. Eager early users, a...